Sun Pharmaceutical Industries Ltd. Stock price

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Delayed NSE India S.E. 03:30:11 2024-02-26 am EST 5-day change 1st Jan Change
1,556 INR -0.37% Intraday chart for Sun Pharmaceutical Industries Ltd. +1.71% +23.56%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2024 * 485B 5.86B Sales 2025 * 538B 6.5B Capitalization 3,746B 45.21B
Net income 2024 * 93.09B 1.12B Net income 2025 * 113B 1.36B EV / Sales 2024 * 7.5 x
Net cash position 2024 * 108B 1.31B Net cash position 2025 * 166B 2.01B EV / Sales 2025 * 6.65 x
P/E ratio 2024 *
40.2 x
P/E ratio 2025 *
33.3 x
Employees 41,000
Yield 2024 *
0.78%
Yield 2025 *
0.89%
Free-Float 45.32%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.43%
1 week+1.60%
Current month+9.60%
1 month+10.98%
3 months+30.49%
6 months+39.18%
Current year+23.43%
More quotes
1 week
1 512.25
Extreme 1512.25
1 568.45
1 month
1 355.20
Extreme 1355.2
1 568.45
Current year
1 257.15
Extreme 1257.15
1 568.45
1 year
922.45
Extreme 922.45
1 568.45
3 years
562.10
Extreme 562.1
1 568.45
5 years
312.00
Extreme 312
1 568.45
10 years
312.00
Extreme 312
1 568.45
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder 68 81-12-31
Director of Finance/CFO - 17-06-18
Members of the board TitleAgeSince
Founder 68 81-12-31
Director/Board Member 66 21-05-20
Director/Board Member 63 23-06-14
More insiders
Date Price Change Volume
24-02-26 1,556 -0.37% 530 190
24-02-23 1,561 +0.21% 1,340,283
24-02-22 1,558 +0.95% 1,981,678
24-02-21 1,543 +0.31% 1,993,748
24-02-20 1,539 +0.56% 2,230,669

Delayed Quote NSE India S.E., February 26, 2024 at 02:41 am EST

More quotes
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
37
Last Close Price
1,561 INR
Average target price
1,522 INR
Spread / Average Target
-2.49%
Consensus
  1. Stock
  2. Equities
  3. Stock Sun Pharmaceutical Industries Ltd. - NSE India S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW